erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study..

he described the failure to send the patient for a ct scan on her hip as another "missed opportunity"...